• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

VDAC1 的部分还原增强了转 Tau 小鼠模型中的线粒体自噬、自噬和突触活性。

A partial reduction of VDAC1 enhances mitophagy, autophagy, synaptic activities in a transgenic Tau mouse model.

机构信息

Department of Internal Medicine, Texas Tech University Health Sciences Center, Lubbock, Texas, USA.

Department of Pharmacology and Neuroscience, Texas Tech University Health Sciences Center, Lubbock, Texas, USA.

出版信息

Aging Cell. 2022 Aug;21(8):e13663. doi: 10.1111/acel.13663. Epub 2022 Jul 7.

DOI:10.1111/acel.13663
PMID:35801276
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9381918/
Abstract

Alzheimer's disease (AD) is the most common cause of mental dementia in the aged population. AD is characterized by the progressive decline of memory and multiple cognitive functions, and changes in behavior and personality. Recent research has revealed age-dependent increased levels of VDAC1 in postmortem AD brains and cerebral cortices of APP, APPxPS1, and 3xAD.Tg mice. Further, we found abnormal interaction between VDAC1 and P-Tau in the AD brains, leading to mitochondrial structural and functional defects. Our current study aimed to understand the impact of a partial reduction of voltage-dependent anion channel 1 (VDAC1) protein on mitophagy/autophagy, mitochondrial and synaptic activities, and behavior changes in transgenic TAU mice in Alzheimer's disease. To determine if a partial reduction of VDAC1 reduces mitochondrial and synaptic toxicities in transgenic Tau (P301L) mice, we crossed heterozygote VDAC1 knockout (VDAC1 ) mice with TAU mice and generated double mutant (VDAC1 /TAU) mice. We assessed phenotypic behavior, protein levels of mitophagy, autophagy, synaptic, other key proteins, mitochondrial morphology, and dendritic spines in TAU mice relative to double mutant mice. Partial reduction of VDAC1 rescued the TAU-induced behavioral impairments such as motor coordination and exploratory behavioral changes, and learning and spatial memory impairments in VDAC1 /TAU mice. Protein levels of mitophagy, autophagy, and synaptic proteins were significantly increased in double mutant mice compared with TAU mice. In addition, dendritic spines were significantly increased; the mitochondrial number was significantly reduced, and mitochondrial length was increased in double mutant mice. Based on these observations, we conclude that reduced VDAC1 is beneficial in symptomatic-transgenic TAU mice.

摘要

阿尔茨海默病(AD)是老年人群中最常见的精神痴呆症病因。AD 的特征是记忆和多种认知功能逐渐下降,以及行为和人格的变化。最近的研究表明,AD 大脑和 APP、APPxPS1 和 3xAD.Tg 小鼠的大脑皮质中,与年龄相关的 VDAC1 水平升高。此外,我们发现 AD 大脑中 VDAC1 与 P-Tau 之间存在异常相互作用,导致线粒体结构和功能缺陷。我们目前的研究旨在了解电压依赖性阴离子通道 1(VDAC1)蛋白部分减少对转 AD tau 小鼠的噬线粒体/自噬、线粒体和突触活性以及行为变化的影响。为了确定 VDAC1 的部分减少是否减轻转 AD tau(P301L)小鼠的线粒体和突触毒性,我们将杂合子 VDAC1 敲除(VDAC1-/-)小鼠与 TAU 小鼠杂交,并生成双突变(VDAC1/TAU)小鼠。我们评估了 TAU 小鼠相对于双突变小鼠的表型行为、噬线粒体、自噬、突触和其他关键蛋白的水平、线粒体形态和树突棘。VDAC1 的部分减少挽救了 TAU 诱导的行为损伤,如运动协调和探索性行为变化,以及 VDAC1/TAU 小鼠的学习和空间记忆损伤。与 TAU 小鼠相比,双突变小鼠中噬线粒体、自噬和突触蛋白的水平显著增加。此外,树突棘显著增加;双突变小鼠中线粒体数量显著减少,线粒体长度增加。基于这些观察结果,我们得出结论,减少 VDAC1 对有症状的转 AD tau 小鼠有益。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b27/9381918/ccb3cca32111/ACEL-21-e13663-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b27/9381918/b5da08fc4cde/ACEL-21-e13663-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b27/9381918/d66d0732e23c/ACEL-21-e13663-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b27/9381918/fd5d9259e4f1/ACEL-21-e13663-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b27/9381918/19d61686dcf7/ACEL-21-e13663-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b27/9381918/1891c9230c69/ACEL-21-e13663-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b27/9381918/b47a66ec38b4/ACEL-21-e13663-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b27/9381918/d4a5dc15cd75/ACEL-21-e13663-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b27/9381918/ccb3cca32111/ACEL-21-e13663-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b27/9381918/b5da08fc4cde/ACEL-21-e13663-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b27/9381918/d66d0732e23c/ACEL-21-e13663-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b27/9381918/fd5d9259e4f1/ACEL-21-e13663-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b27/9381918/19d61686dcf7/ACEL-21-e13663-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b27/9381918/1891c9230c69/ACEL-21-e13663-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b27/9381918/b47a66ec38b4/ACEL-21-e13663-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b27/9381918/d4a5dc15cd75/ACEL-21-e13663-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b27/9381918/ccb3cca32111/ACEL-21-e13663-g001.jpg

相似文献

1
A partial reduction of VDAC1 enhances mitophagy, autophagy, synaptic activities in a transgenic Tau mouse model.VDAC1 的部分还原增强了转 Tau 小鼠模型中的线粒体自噬、自噬和突触活性。
Aging Cell. 2022 Aug;21(8):e13663. doi: 10.1111/acel.13663. Epub 2022 Jul 7.
2
A partial reduction of Drp1 improves cognitive behavior and enhances mitophagy, autophagy and dendritic spines in a transgenic Tau mouse model of Alzheimer disease.在阿尔茨海默病转基因 Tau 小鼠模型中,Drp1 的部分减少可改善认知行为,并增强线粒体自噬、自噬和树突棘。
Hum Mol Genet. 2022 Jun 4;31(11):1788-1805. doi: 10.1093/hmg/ddab360.
3
Reduced VDAC1, Maintained Mitochondrial Dynamics and Enhanced Mitochondrial Biogenesis in a Transgenic Tau Mouse Model of Alzheimer's Disease.阿尔茨海默病转基因 Tau 小鼠模型中线粒体 VDAC1 减少、线粒体动力学维持和线粒体生物发生增强。
Int J Mol Sci. 2022 Aug 2;23(15):8561. doi: 10.3390/ijms23158561.
4
Abnormal interaction of VDAC1 with amyloid beta and phosphorylated tau causes mitochondrial dysfunction in Alzheimer's disease.阿尔茨海默病中线粒体功能障碍是由于 VDAC1 与淀粉样β和磷酸化 tau 的异常相互作用引起的。
Hum Mol Genet. 2012 Dec 1;21(23):5131-46. doi: 10.1093/hmg/dds360. Epub 2012 Aug 27.
5
RNA silencing of genes involved in Alzheimer's disease enhances mitochondrial function and synaptic activity.对阿尔茨海默病相关基因进行RNA沉默可增强线粒体功能和突触活性。
Biochim Biophys Acta. 2013 Dec;1832(12):2368-78. doi: 10.1016/j.bbadis.2013.09.008. Epub 2013 Sep 21.
6
Hippocampal mutant APP and amyloid beta-induced cognitive decline, dendritic spine loss, defective autophagy, mitophagy and mitochondrial abnormalities in a mouse model of Alzheimer's disease.阿尔茨海默病小鼠模型中海马突变 APP 和淀粉样β诱导的认知衰退、树突棘丢失、自噬、线粒体自噬和线粒体异常。
Hum Mol Genet. 2018 Apr 15;27(8):1332-1342. doi: 10.1093/hmg/ddy042.
7
Selective serotonin reuptake inhibitor citalopram ameliorates cognitive decline and protects against amyloid beta-induced mitochondrial dynamics, biogenesis, autophagy, mitophagy and synaptic toxicities in a mouse model of Alzheimer's disease.选择性 5-羟色胺再摄取抑制剂西酞普兰可改善认知衰退,并防止阿尔茨海默病小鼠模型中淀粉样β诱导的线粒体动力学、生物发生、自噬、线粒体自噬和突触毒性。
Hum Mol Genet. 2021 May 28;30(9):789-810. doi: 10.1093/hmg/ddab091.
8
Is the mitochondrial outermembrane protein VDAC1 therapeutic target for Alzheimer's disease?线粒体外膜蛋白VDAC1是阿尔茨海默病的治疗靶点吗?
Biochim Biophys Acta. 2013 Jan;1832(1):67-75. doi: 10.1016/j.bbadis.2012.09.003. Epub 2012 Sep 17.
9
Amyloid Beta and Phosphorylated Tau-Induced Defective Autophagy and Mitophagy in Alzheimer's Disease.淀粉样β和磷酸化 tau 诱导的阿尔茨海默病中的自噬和 mitophagy 缺陷。
Cells. 2019 May 22;8(5):488. doi: 10.3390/cells8050488.
10
VDAC1, mitochondrial dysfunction, and Alzheimer's disease.电压依赖性阴离子通道 1、线粒体功能障碍与阿尔茨海默病。
Pharmacol Res. 2018 May;131:87-101. doi: 10.1016/j.phrs.2018.03.010. Epub 2018 Mar 15.

引用本文的文献

1
Proteomic and non-proteomic changes of presynaptic proteins in animal models of Alzheimer's disease: A meta-analysis 2015-2023.阿尔茨海默病动物模型中突触前蛋白的蛋白质组学和非蛋白质组学变化:2015 - 2023年的一项荟萃分析
J Alzheimers Dis. 2025 Aug 1;107(2):13872877251362212. doi: 10.1177/13872877251362212.
2
Is the Voltage-Dependent Anion Channel a Major Player in Neurodegenerative Diseases?电压依赖性阴离子通道是神经退行性疾病的主要参与者吗?
Int J Mol Sci. 2025 Jun 26;26(13):6138. doi: 10.3390/ijms26136138.
3
Organelle perturbation in Alzheimer's disease: do intracellular amyloid-ß and the fragmented Golgi mediate early intracellular neurotoxicity?

本文引用的文献

1
Broad activation of the Parkin pathway induces synaptic mitochondrial deficits in early tauopathy.广泛激活 Parkin 通路可导致早期 tau 病中的突触线粒体缺陷。
Brain. 2022 Mar 29;145(1):305-323. doi: 10.1093/brain/awab243.
2
Deregulated mitochondrial microRNAs in Alzheimer's disease: Focus on synapse and mitochondria.阿尔茨海默病中线粒体 microRNAs 的失调:聚焦于突触和线粒体。
Ageing Res Rev. 2022 Jan;73:101529. doi: 10.1016/j.arr.2021.101529. Epub 2021 Nov 20.
3
Protective effects of a small-molecule inhibitor DDQ against tau-induced toxicities in a transgenic tau mouse model of Alzheimer's disease.
阿尔茨海默病中的细胞器功能紊乱:细胞内淀粉样β蛋白和破碎的高尔基体是否介导早期细胞内神经毒性?
Front Cell Dev Biol. 2025 Apr 15;13:1550211. doi: 10.3389/fcell.2025.1550211. eCollection 2025.
4
VDAC1 Inhibition Protects Against Noise-Induced Hearing Loss via the PINK1/Parkin Pathway.电压依赖性阴离子通道1(VDAC1)抑制通过PINK1/帕金(Parkin)途径预防噪声性听力损失。
CNS Neurosci Ther. 2025 Apr;31(4):e70410. doi: 10.1111/cns.70410.
5
VDAC1-Targeted NHK1 Peptide Recovers Mitochondrial Dysfunction Counteracting Amyloid-β Oligomers Toxicity in Alzheimer's Disease.靶向电压依赖性阴离子通道1(VDAC1)的NHK1肽可恢复线粒体功能障碍,对抗阿尔茨海默病中淀粉样β寡聚体的毒性作用。
Aging Cell. 2025 Apr 13:e70069. doi: 10.1111/acel.70069.
6
VDAC1 Inhibition Mitigates Inflammatory Status and Oxidative Stress in Epileptic Mice Treated with the Ketogenic Diet.电压依赖性阴离子通道1抑制减轻生酮饮食治疗的癫痫小鼠的炎症状态和氧化应激。
Neurochem Res. 2025 Mar 14;50(2):118. doi: 10.1007/s11064-025-04366-2.
7
Distinct neuronal vulnerability and metabolic dysfunctions are characteristic features of fast-progressing Alzheimer's patients with Lewy bodies.不同的神经元易损性和代谢功能障碍是患有路易体的快速进展性阿尔茨海默病患者的特征性表现。
J Biol Chem. 2025 Apr;301(4):108396. doi: 10.1016/j.jbc.2025.108396. Epub 2025 Mar 10.
8
Hippocampal mitophagy alterations in MAPT-associated frontotemporal dementia with parkinsonism.与微管相关蛋白tau病伴帕金森综合征相关的额颞叶痴呆中的海马线粒体自噬改变
Acta Neuropathol Commun. 2025 Feb 24;13(1):41. doi: 10.1186/s40478-025-01955-8.
9
Role of Mitochondrial Dysfunctions in Neurodegenerative Disorders: Advances in Mitochondrial Biology.线粒体功能障碍在神经退行性疾病中的作用:线粒体生物学进展
Mol Neurobiol. 2025 Jun;62(6):6827-6855. doi: 10.1007/s12035-024-04469-x. Epub 2024 Sep 13.
10
Role of Tau Protein in Neurodegenerative Diseases and Development of Its Targeted Drugs: A Literature Review.tau 蛋白在神经退行性疾病中的作用及其靶向药物的开发:文献综述。
Molecules. 2024 Jun 13;29(12):2812. doi: 10.3390/molecules29122812.
小分子抑制剂 DDQ 对阿尔茨海默病转基因 tau 小鼠模型中 tau 诱导的毒性的保护作用。
Hum Mol Genet. 2022 Mar 31;31(7):1022-1034. doi: 10.1093/hmg/ddab285.
4
Protective effects of mitophagy enhancers against amyloid beta-induced mitochondrial and synaptic toxicities in Alzheimer disease.促进线粒体自噬对阿尔茨海默病β淀粉样蛋白诱导的线粒体和突触毒性的保护作用。
Hum Mol Genet. 2022 Feb 3;31(3):423-439. doi: 10.1093/hmg/ddab262.
5
Defective mitophagy and synaptic degeneration in Alzheimer's disease: Focus on aging, mitochondria and synapse.阿尔茨海默病中的缺陷性线粒体自噬和突触退化:聚焦于衰老、线粒体和突触。
Free Radic Biol Med. 2021 Aug 20;172:652-667. doi: 10.1016/j.freeradbiomed.2021.07.013. Epub 2021 Jul 8.
6
Protective effects of a small molecule inhibitor, DDQ against amyloid beta in Alzheimer's disease.小分子抑制剂 DDQ 对阿尔茨海默病中淀粉样β的保护作用。
Mitochondrion. 2021 Jul;59:17-29. doi: 10.1016/j.mito.2021.04.005. Epub 2021 Apr 9.
7
Anti-brain Aging Effects of Small Molecule Inhibitor DDQ.小分子抑制剂 DDQ 的抗脑衰老作用。
Mol Neurobiol. 2021 Jul;58(7):3588-3600. doi: 10.1007/s12035-021-02360-7. Epub 2021 Mar 26.
8
Effect of Increased IL-1β on Expression of HK in Alzheimer's Disease.白细胞介素-1β增加对阿尔茨海默病中己糖激酶表达的影响。
Int J Mol Sci. 2021 Jan 28;22(3):1306. doi: 10.3390/ijms22031306.
9
Synaptic basis of Alzheimer's disease: Focus on synaptic amyloid beta, P-tau and mitochondria.阿尔茨海默病的突触基础:聚焦于突触淀粉样β、P-tau 和线粒体。
Ageing Res Rev. 2021 Jan;65:101208. doi: 10.1016/j.arr.2020.101208. Epub 2020 Nov 4.
10
Mitophagy coordination with retrograde transport ensures the integrity of synaptic mitochondria.线粒体自噬与逆行转运的协调确保了突触线粒体的完整性。
Autophagy. 2020 Oct;16(10):1925-1927. doi: 10.1080/15548627.2020.1810919. Epub 2020 Aug 23.